284 related articles for article (PubMed ID: 26941073)
1. Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies.
Avgeris M; Scorilas A
Expert Opin Ther Targets; 2016 Jul; 20(7):801-18. PubMed ID: 26941073
[TBL] [Abstract][Full Text] [Related]
2. Targeting the kallikrein-related peptidases for drug development.
Sotiropoulou G; Pampalakis G
Trends Pharmacol Sci; 2012 Dec; 33(12):623-34. PubMed ID: 23089221
[TBL] [Abstract][Full Text] [Related]
3. Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challenges.
Cereda V; Formica V; Menghi A; Pellicori S; Roselli M
Expert Opin Investig Drugs; 2015; 24(7):929-47. PubMed ID: 25858813
[TBL] [Abstract][Full Text] [Related]
4. Targeting kallikrein-related peptidases in prostate cancer.
Mavridis K; Avgeris M; Scorilas A
Expert Opin Ther Targets; 2014 Apr; 18(4):365-83. PubMed ID: 24571737
[TBL] [Abstract][Full Text] [Related]
5. Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer.
Pampalakis G; Sotiropoulou G
Biochim Biophys Acta; 2007 Sep; 1776(1):22-31. PubMed ID: 17629406
[TBL] [Abstract][Full Text] [Related]
6. Overview of tissue kallikrein and kallikrein-related peptidases in breast cancer.
Figueroa CD; Molina L; Bhoola KD; Ehrenfeld P
Biol Chem; 2018 Sep; 399(9):937-957. PubMed ID: 29885274
[TBL] [Abstract][Full Text] [Related]
7. Evolutionary history of tissue kallikreins.
Pavlopoulou A; Pampalakis G; Michalopoulos I; Sotiropoulou G
PLoS One; 2010 Nov; 5(11):e13781. PubMed ID: 21072173
[TBL] [Abstract][Full Text] [Related]
8. Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis.
Yoon H; Blaber SI; Evans DM; Trim J; Juliano MA; Scarisbrick IA; Blaber M
Protein Sci; 2008 Nov; 17(11):1998-2007. PubMed ID: 18697857
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of kallikrein-related peptidases: An overview.
Masurier N; Arama DP; El Amri C; Lisowski V
Med Res Rev; 2018 Mar; 38(2):655-683. PubMed ID: 28609548
[TBL] [Abstract][Full Text] [Related]
10. Activation profiles and regulatory cascades of the human kallikrein-related peptidases.
Yoon H; Laxmikanthan G; Lee J; Blaber SI; Rodriguez A; Kogot JM; Scarisbrick IA; Blaber M
J Biol Chem; 2007 Nov; 282(44):31852-64. PubMed ID: 17823117
[TBL] [Abstract][Full Text] [Related]
11. Functional roles of human kallikrein-related peptidases.
Sotiropoulou G; Pampalakis G; Diamandis EP
J Biol Chem; 2009 Nov; 284(48):32989-94. PubMed ID: 19819870
[TBL] [Abstract][Full Text] [Related]
12. A potential role for tissue kallikrein-related peptidases in human cervico-vaginal physiology.
Shaw JL; Diamandis EP
Biol Chem; 2008 Jun; 389(6):681-8. PubMed ID: 18627298
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there.
Pasic MD; Olkhov E; Bapat B; Yousef GM
Biol Chem; 2012 Apr; 393(5):319-30. PubMed ID: 22505515
[TBL] [Abstract][Full Text] [Related]
14. Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer.
Loessner D; Goettig P; Preis S; Felber J; Bronger H; Clements JA; Dorn J; Magdolen V
Expert Opin Ther Targets; 2018 Sep; 22(9):745-763. PubMed ID: 30114962
[TBL] [Abstract][Full Text] [Related]
15. Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).
Goettig P; Magdolen V; Brandstetter H
Biochimie; 2010 Nov; 92(11):1546-67. PubMed ID: 20615447
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometry based proteomics analyses in kallikrein-related peptidase research: implications for cancer research and therapy.
Silva LM; Clements JA
Expert Rev Proteomics; 2017 Dec; 14(12):1119-1130. PubMed ID: 29025353
[TBL] [Abstract][Full Text] [Related]
17. Kallikrein-related peptidases (KLKs) and the hallmarks of cancer.
Filippou PS; Karagiannis GS; Musrap N; Diamandis EP
Crit Rev Clin Lab Sci; 2016 Aug; 53(4):277-91. PubMed ID: 26886390
[TBL] [Abstract][Full Text] [Related]
18. Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance.
Avgeris M; Mavridis K; Scorilas A
Biol Chem; 2012 Apr; 393(5):301-17. PubMed ID: 22505514
[TBL] [Abstract][Full Text] [Related]
19. Activation profiles of human kallikrein-related peptidases by matrix metalloproteinases.
Yoon H; Blaber SI; Li W; Scarisbrick IA; Blaber M
Biol Chem; 2013 Jan; 394(1):137-47. PubMed ID: 23241590
[TBL] [Abstract][Full Text] [Related]
20. Evolution of the plasma and tissue kallikreins, and their alternative splicing isoforms.
Koumandou VL; Scorilas A
PLoS One; 2013; 8(7):e68074. PubMed ID: 23874499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
